The Genus Cetraria s. str.: Comparison
View Latest Version
Please note this is a comparison between Version 3 by Jessie Wu and Version 2 by Jessie Wu.

The genus Cetraria s. str. (Parmeliaceae family, Cetrarioid clade) consists of 15 species of mostly erect brown or greenish yellow fruticose or subfoliose thallus. These Cetraria species have a cosmopolitan distribution, being primarily located in the Northern Hemisphere, in North America and in the Eurasia area. 

  • Cetraria
  • traditional uses
  • Pseudomonas aeruginosa

1. Traditional Uses

Among the species of the genus Cetraria, C. islandica (L.) Ach. has been the most widely used in traditional medicine. Its folk uses have been reported in a variety of documents, including handbooks, pharmacopoeias, compendia and pharmacognostical texts [1]. The main uses for C. islandica, commonly known as Iceland moss, are for the treatment of digestive and respiratory diseases. Herbal preparation varies from decoctions, tinctures and aqueous extracts to infusions. Hence, in Iceland, C. islandica has been used to the relief of both gastric and duodenal ulcers [2]. Moreover, decoctions of C. islandica were used to treat colds in Finland [3]. Furthermore, for centuries, C. islandica was famous as a laxative and antitussive in Central Europe. In addition to uses to treat respiratory and digestive conditions, C. islandica has been used in other countries for other medical purposes. This is the case in Sweden, where it has been used to treat nephritis and diabetes [4], and in Turkey, where it has been employed as a hemostatic and antihemorrhoidal agent [5][6]. Moreover, C. islandica has been used for tuberculosis in several countries including Spain, France, and Turkey [3][6][7]. These medicinal properties have been attributed mainly to its lichen acids, such as fumaroprotocetraric acid (2.6–11.5%), protocetraric acid (0.2–0.3%), protolichesterinic acid (0.1–1.5%) and usnic acid (0.04%) [8][9].
Based on the therapeutic benefits of C. islandica, comminuted herbal substances and soft extracts of this lichen in the form of syrup, oral gum, and lozenges have been marketed to relieve dry and irritating coughs and hoarseness. Moreover, combined commercial drug products have been developed that contain C. islandica together with other medicinal plants (Thymus vulgaris L., Hyssopus officinalis L., Saponaria officinalis L. and Marrubium vulgare L., among others) for the inflammatory processes of the upper airway, for the management of bronchial secretions and for the alleviation of coughs [1].
Other ethnobotanical studies have revealed traditional uses for other Cetraria species. Hence, in the Catalan Pyrenees (Spain), Cetraria cucullata (Bellardi) Ach. has been employed for asthma [7].
Many of the traditional uses of Cetraria spp. have been validated, such as antidiabetic and anti-inflammatory, and other new pharmacological activities are being investigated, such as cytotoxic and genotoxic/antigenotoxic, which researchers will discuss later in the section of pharmacological activities.
In addition to the medicinal uses of C. islandica, its nutritional value is noteworthy. It is mainly consumed as tea. Moreover, in Italy, it is a food supplementation product valued for its digestive-facilitating properties [1]. In Northern Europe, during times of famine, it was used for bread, sometimes mixed with rice or flour [10][11]. Furthermore, C. islandica is approved as a flavoring for alcoholic beverages in United States [12]. In Iceland, C. islandica is used in a variety of recipes including soups, porridges and sausages, and is added to “skyr” (curd) [9], and it is also marketed as a bitter alcoholic beverage (38% alcohol content) called “Cetraria islandica schnapps” [11]. On the other hand, in Russia, during the years 1942–1943, C. islandica was used to industrially extract glucose because of the beet sugar scarcity [11]. Moreover, the lichen species Cetraria ericetorum Opiz was chopped up and added to soups for flavoring [13]. In addition to food uses in humans, the species C. islandica has been used as food for pigs and cows, especially during World War II [13]. Finally, it is also worth mentioning its uses in cosmetics. C. islandica is part of the composition of diversity cosmetic products, including shampoos and conditioners, deodorants, toothpastes, exfoliating and anti-cellulite creams, manicure and pedicure products, and aftershave lotions. Moreover, the lichen Cetraria nivalis (L.) Ach. is used in rejuvenating cream formulations [14].

2. Therapeutic Potential

2.1. Antibacterial, Antifungal and Antitrypanosomal Activities

The antibacterial and antifungal activities of species of the genus Cetraria have been investigated for Cetraria pinastri, Cetraria aculeata and Cetraria islandica. These lichen species have shown antibacterial activity against a broad group of both Gram-positive and Gram-negative bacteria. Hence, the Gram-positive microorganisms sensitive to the methanol extract of Cetraria pinastri were Enterococcus fecalis (Minimum Inhibitory Concentration (MIC) 0.23 mg/mL), Micrococcus lysodeikticus (MIC 0.46 mg/mL) and Staphylococcus aereus (MIC 0.94 mg/mL). The only Gram-negative bacteria that was sensitive to the methanol extract of Cetraria pinastri was Escherichia coli, with an MIC value of 1.87 mg/mL [15]. In another study, the antimicrobial activity of the ethanol, acetone and diethylether extracts of Cetraria acuelata against 12 different Gram-positive (Bacillus cereus, Bacillus subtilis, Listeria monocytogenes, Staphylococcus aureus and Streptococcus faecalis) and Gram-negative (Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Pseudomonas syringae, Proteus vulgaris, Aeromonas hydrophila and Yersinia enterocolitica) bacteria was investigated. The three extracts tested showed antimicrobial activity against all bacteria species, except for the Gram-negative bacteria Pseudomonas syringae, Klebsiella pneumoniae and Yersinia enterocolitica. The most potent of the three tested Cetraria aculeata extracts was the diethylether extract, being especially active against the Gram-positive bacteria Bacillus cereus, Bacillus subtilis, Listeria monocytogenes and Streptococcus faecalis, and against the Gram-negative bacteria Pseudomonas aeruginosa and Proteus vulgaris, with MIC values of 8460 µg/mL [16]. Regarding the antimicrobial activity of Cetraria islandica, the extracts of methanol, acetone, water, and light petrolatum were assayed against Helicobacter pylori by using the Kirby and Bauery disk diffusion test. The light petrolatum extract of Cetraria islandica was the one that showed the greatest inhibitory capacity, followed by the acetone extract. However, the methanol and water extracts showed no activity. In addition, it was demonstrated that the compound responsible for the antimicrobial activity in the light petrolatum extract was the protolichesterinic acid [17]. In another study, the antimicrobial activity of the methanol extract of Cetraria islandica against Gram-positive species such as Staphylococcus aureus, Bacillus subtilis and Bacillus cereus, and against Gram-negative species such as Escherichia coli and Proteus mirabilis, was evaluated. The results show that the methanol extract of Cetraria islandica was more active against Escherichia coli with an MIC value of 2.5 mg/mL, followed by Staphylococcus aureus (MIC 1.25 mg/mL), Proteus mirabilis (MIC 1.25 mg/mL), Bacillus subtilis (MIC 0.625 mg/mL) and Bacillus cereus (MIC 0.312 mg/mL) [18]. In addition to studies evaluating the antibacterial activity of the lichen extracts from Cetraria species, the antimicrobial action of the compound protolichesterinic acid, isolated from Cetraria, Cetraria aculeata and Cetraria islandica, was investigated against different types of Gram-positive and Gram-negative bacteria. Hence, in one study, the protolichesterinic acid was active against Escherichia coli (MIC 7341 µg/mL), Bacillus subtilis (MIC 7341 µg/mL), Pseudomonas aeruginosa (MIC 7341 µg/mL) and Listeria monocytogenes (MIC 3670 µg/mL) [16]. In another study, the inhibitory capacity of the protolichesterinic acid was evaluated against a total of 35 Helicobacter pylori strains randomly selected from human biopsy samples, obtaining MIC values ranging from 16 to 64 µg/mL [17]. Apart from their antibacterial activity, Cetraria species, specifically Cetraria aculeata, Cetraria pinastri and Cetraria islandica, have been found to be active against pathogenic fungi. Hence, the methanol extract of Cetraria pinastri showed antifungal activity against Acremonium chrysogenum (MIC 3.75 mg/mL), Alternaria alternata (MIC 1.87 mg/mL), Aspergillus flavus (MIC 7.5 mg/mL), Aspergillus niger (MIC3.75 mg/mL), Candida albicans (MIC 1.87 mg/mL), Cladosporium cladosporioides (MIC 0.94 mg/mL), Fusarium oxysporum (MIC 7.5 mg/mL), Mucor mucedo (MIC 7.5 mg/mL), Paecilomyces variotii (MIC 15 mg/mL), Penicillium verrucosum (MIC 15 mg/mL) and Trichoderma harsianum (MIC 3.75 mg/mL). In another study, the ethanol, acetone, and diethyl ether extracts of Cetraria aculeata were assayed against the fungal species Penicillum sp., Cladosporium sp., Fusarium oxysporum, Fusarium culmorum, Rhizopus sp., Fusarium moniliforme, Fusarium solani and Aspergillus sp. The results show that none of the extracts of Cetraria aculeata had antifungal activity [15][16]. Finally, the methanol extract of Cetraria islandica was investigated on Aspergillus flavus, Candida albicans, Fusarium oxysporum, Penicillium purpurescens and Trichoderma harsianum species. Cetraria islandica showed a high antifungal activity against Aspergillus flavus and Penicillium purpurescens, with MIC values of 5 mg/mL, followed by its activity against Fusarium oxysporum and Trichoderma harsianum, with MIC values of 2.5 mg/mL. The lowest antifungal activity of the methanol extract of Cetraria islandica was against Candida albicans (MIC 1.25 mg/mL) [18]. In addition to the antifungal and antibacterial activity studies, the antitrypanosomal activity against Trypanosoma brucei brucei of bioactive compounds isolated from Cetraria islandica species was also evaluated. Protolichesterinic acid, fumarprotocetraric acid, lichesterinic acid and protocetraric acid were isolated. It was observed that only protolichesterinic acid (MIC 12.5 µM) and lichesterinic acid (MIC 6.30 µM) showed antitrypanosomal activity, with protolichesterinic acid being more effective [19].

2.2. Antioxidant Activity

Oxidative stress is characterized by an imbalance between the production of reactive species (ROS) and the antioxidant defense activity. This pathological state has been associated with many chronic and/or degenerative diseases, such as diabetes, Alzheimer’s disease, and cardiovascular disease. The use of exogenous antioxidants that act as scavengers or that modulate the endogenous antioxidant system is one of the most promising therapies used to deal with oxidative stress. In this context, phenolic compounds have turned out to be powerful antioxidants. The efficacy is directly related to the number of hydroxyl groups in the phenolic structure [20]. Lichens produce unique phenolic compounds as secondary metabolites that have aroused great research interest due to their antioxidant capacity [21]. Ranković B et al. evaluated the antioxidant activity of the methanol extract of Cetraria pinastri species by measuring the oxidation products of linoleic acid. The results have revealed that this lichen species was able to inhibit linoleic acid oxidation by 48.8%. This activity is related to its high polyphenol content of 32.9 mg/g in the dry extract [15]. Likewise, antioxidant activity studies have been carried out with the methanol extract and the ethyl acetate extract of Cetraria aculeata. In general, the antioxidant capacity of the methanol extract was higher than that of the ethyl acetate extract. Hence, the methanol extract showed an IC50 value of 51.65 µg/mL in the 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay, a value of 45.55 µg/mL for lipid peroxidation inhibition capacity, a value of 50.43 µg/mL for ferrous ion chelating capacity and a value of 90.1 µg/mL for hydroxyl radical scavenging activity. Regarding antioxidant enzymes, the methanol extract of C. aculeata increased superoxide dismutase (SOD) and glutathione peroxidase (GPx) enzymes’ activities. On the contrary, a slight increase in malondialdehyde (MDA) levels and a decrease in reduced glutathione (GSH) levels were also observed at low doses [22]. On the other hand, the lichen in which the antioxidant activity has been the most studied is Cetraria islandica. Hence, the methanol extract of Cetraria islandica exhibited a high reduction capability and powerful free radical scavenging, as shown in the DPPH assay (IC50 678.38 μg/mL), superoxide anion assay (IC50 792.48 μg/mL) and reducing power assay (from 0.0512 μg/mL to 0.4562 μg/mL) [18]. In another study, Kotan E. et al. investigated the antioxidant ability of the methanol extract of Cetraria islandica (5 and 10 µg/mL) in an aflatoxin B1 induced oxidative stress model in blood lymphocytes from healthy non-smoking volunteers. The methanol extracts of this lichen species increased SOD and glutathione peroxidase (GPx) enzyme activities, and decreased MDA levels. The most protective concentration of Cetraria islandica was 5 µg/mL [23]. In addition to the methanol extract, the aqueous extract of Cetraria islandica has shown antioxidant activity using the thiocyanate method and the reducing antioxidant power, superoxide anion radical and DPPH assays. Different concentrations of the aqueous extract of Cetraria islandica (50, 100 and 250 µg) inhibited the peroxidation of linoleic acid by 96 to 100%. Moreover, this extract reduced iron from its ferric state to its ferrous state in a significant and concentration-dependent manner, this activity being higher than in the reference compound BHT. Moreover, the aqueous extract of Cetraria islandica at a concentration of 100 μg showed a higher superoxide radical scavenging activity than the reference compounds hydroxybutylanisole (BHA), butylated hydroxytoluene (BHT), and quercetin [24]. Furthermore, the ethanol extracts of Cetraria islandica (96%, 70% and 40%) showed antioxidant activity. The DPPH assay showed that the ethanol extract 70% and ethanol extract 40% had IC50 values of 2.40 mg/mL and 2.45 mg/mL; the Ferric Reducing Antioxidant Power (FRAP) assay revealed that the ethanol extract 96% had the highest value of 486 μmol/L, and the 2, 2′-Azinobis-3-ethyl-benzo-thiazoline-6-sulphonic acid (ABTS) assay demonstrated that the ethanol extract 40% of this lichen was the most active [25]. In another study, Kosanic M. et al. compared the antioxidant activities of different extracts (methanol, water, and acetone) of Cetraria islandica by using the DPPH assay, reducing antioxidant power method and superoxide anion radical assay. This study revealed that the methanol extract had the highest activity in all these methods, followed by the acetone extract and aqueous extract [26]. Recently, it has been observed that melanin extracted from Cetraria islandica also possesses free radical scavenging and reducing capacity in the DPPH assay, with an IC50 of 405 μg/mL [27]. Finally, based on the antioxidant properties and considering the implications of oxidative processes in diabetes and neurodegenerative diseases, there are several studies focused on the protective effect of Cetraria islandica. Hence, the aqueous extract of this lichen species increased the activity of the antioxidant enzymes SOD, catalase (CAT), and GPx, and reduced the levels of the lipid peroxidation biomarker MDA in human erythrocytes with type 1 diabetes mellitus [28]. Moreover, the aqueous extract of Cetraria islandica decreased the total oxidative stress (TOS) and increased the total antioxidant capacity (TAC) in streptozotocin-induced Diabetes Mellitus type 1 Sprague-Dawley rats [29]. Using the same model, the aqueous extract of Cetraria islandica (250–500 mg/kg/day) increased the levels of SOD, CAT and GSH, and reduced the levels of MDA [30][31][32]. Regarding neuroprotection studies, the protective role of Cetraria islandica and its isolated secondary metabolite fumarprotocetraric acid has been demonstrated in a hydrogen peroxide-induced oxidative stress model on human U373MG astrocytoma cells and human SH-SY5Y neuroblastoma cells. The methanol extract of Cetraria islandica at 10 µg/mL concentration increased cell viability, reduced intracellular ROS production and MDA levels, and increased the ratio of reduced/oxidized glutathione (GSH/GSSG). The depsidone fumarprotocetraric acid at 1 μg/mL in the neurons model and 25 μg/mL in the astrocytes decreased lipid peroxidation levels and intracellular ROS production and increased the ratio GSH/GSSG. Moreover, this compound ameliorated the H2O2-induced mitochondrial dysfunction and alterations in calcium homeostasis and inhibited apoptotic cell death. Its neuroprotective activity is related, at least in part, to its ability to activate the Nrf2 pathway that regulates antioxidant enzymes. Furthermore, both the lichen extract and fumarprotocetraric acid showed scavenging activities in the oxygen radical absorbance capacity (ORAC) assay (value of 3.06 µmol TE/mg and 5. 07 μmol TE/mg, respectively) and in the DPPH assay (IC50 value of 1183.55 µg/mL and 1393.83 μg/mL, respectively) [33][34].

2.3. Immunomodulatory and Anti-Inflammatory Activities

The immunomodulatory activity has been investigated on Cetraria islandica aqueous extracts and the isolated compounds fumarprotocetraric acid and protolichesterinic acid, and the polysaccharides lichenan and isolichenan on the maturation of dendritic cells. This study showed that the aqueous extract and the polysaccharide lichenan reduced the IL-12p40/IL-10 ratio and CD209 expression and increased CD86 expression. Moreover, this lichen extract showed anti-inflammatory properties at a dose of 2.5 mg/kg on a BSA-induced arthritis rat model, as evidenced in the reduction in the diameter between the right and left knees [35]. It is also noteworthy that the study on the polysaccharide α-1,3/1,4-D-Glucan (Ci3) isolated from Cetraria islandica (100 ug/mL) showed an increase in granulocytic phagocytosis and a decrease in complement-induced hemolysis [36].

2.4. Cytotoxic, Genotoxic and Antigenotoxic Activities

The cytotoxic activities of the lichen species Cetraria acuelata and Cetraria islandica and their isolated bioactive compounds have been evaluated on different types of malignant cells. Hence, the methanol extract of Cetraria islandica reduced the cell viability of the human breast cancer cells (MCF-7) (IC50 value of 19.51 µg/mL), the human liver cancer cells (HepG2) (IC50 value of 181.05 µg/mL), human melanoma cells (FemX) (IC50 value of 22.68 μg/mL) and human colon carcinoma cells (LS174) (IC50 value of 33.74 μg/mL) [18][33]. On the other hand, the ethanol extract of Cetraria islandica was able to reduce cell viability in MCF-7 cells (IC50 9.2047 × 10−5 g/mL), also showing an increase in protein levels of AMP-activated kinases-α1 (AMPK-α1) and ERK1/2 [37]. The compound protolichesterinic acid, isolated from Cetraria islandica, decreased cell viability and caused morphological changes at a concentration of 20 µg/mL on breast carcinomas T-47D and ZR-75-1 and erythro-leukaemia K-562 cells. Moreover, this secondary metabolite inhibited DNA synthesis at the concentrations of 1.1 µg/mL on ZR-75-1 cells, 3.8 µg/mL on T-47D cells and 11.2 µg/mL on K-562 cells. This activity is related to the ability of protolichesterinic acid to inhibit 5-lipoxygenase [38]. Thorsteinsdottir et al. conducted a study in which it was observed that protolichesterinic acid, in addition to reducing human lung cancer cells’ (A549) viability, also induced a decrease in Leucine Rich Repeat Containing 8 VRAC Subunit A (LRRC8A) protein expression, as well as volume-sensitive taurine release under hypotonic conditions [39]. On the other hand, the fumarprotocetraric acid, isolated from Cetraria islandica, did not inhibit the cell growth of the human cells T-47D (breast) and Panc-1 (pancreas) [40]. Moreover, the lichenan from Cetraria islandica was also not active against the human myeloid leukemia U937 cells [41]. In addition to Cetraria islandica, the cytotoxic activity of Cetraria aculeata has been studied. The acetone extract of this lichen species was active against HeLa (human uterus carcinoma) (IC50 value of 200 μg/mL), A549 (human small lung carcinoma) (IC50 value of 500 μg/mL) and 5RP7 (c-H-ras transformed-rat embryonic fibroblasts) (IC50 value of 280 μg/mL) [42]. Regarding the studies performed to evaluate the genotoxic/antigenotoxic activities of Cetraria species, it has been highlighted that the species Cetraria aculeata showed a significant antigenotoxic effect on TA98 and TA100 strains of Salmonella typhimurium but had no effect in human lymphocytes [42]. On the other hand, the methanol extract showed antigenotoxic activity against Salmonella typhimurium strains TA1535 and TA1537, and a slight decrease in sister chromatid exchange (SCE) formation [43]. In another work, it has been shown that the methanol extract of Cetraria islandica (from 50 to 200 μg/mL) had genotoxic potential in cultured peripheral venous blood from healthy donors by increasing both the number of BN cells containing micronuclei (MNi) and the number of MNi in BN cells [18].

2.5. Cell Differentiation and Depigmentation Activities

The effect of β-1,3/1,4-Glucan (Lichenan), isolated from Cetraria islandica, on cell differentiation has recently been evaluated in primary normal human epidermal keratinocytes (NHEK) and HaCaT keratinocytes using immunofluorescence. A decrease in cell proliferation and an increase in protein expression of specific differentiation-related markers such as cytokeratin 10 (CK10) and involucrin were observed in NHEK cells. In addition, the gene expressions of CK, involucrin, transglutaminase, loricrin and filaggrin genes, which are involved in cell differentiation, were also increased [44]. The depigmenting activity was evaluated in chloroform, chloroform–methanol, methanol, and water extracts of Cetraria islandica species. The chloroform–methanol extract showed the highest inhibition capacity on tyrosinase (IC50 86 µg/mL). A cell viability assay was performed on human melanoma cells (MeWo) with IC50 values of 264 µg/mL. Melanin assays demonstrated a significant reduction in melanin levels. On the other hand, zebrafish embryo models were used to determine the melanogenesis effects of the extract showing an inhibition of melanogenesis, and therefore a reduction in pigmentation [45].
Table 1. Pharmacological activities of Cetraria spp.
Table 1. Pharmacological activities of Cetraria spp.
Lichen Species Extracts/Active Compounds Experimental Model Activities Results References
Cetraria aculeata

(Schreb.) Fr.		 Diethyl ether extract Ethanol extract

Acetone extract		 Gram-positive: Bacillus cereus, Staphylococcus aureus, Bacillus subtilis, Streptococcus, Listeria monocytogenes

Gram-negative: 		Escherichia coli, Proteus vulgaris, Pseudomonas aeruginosa, Pseudomonas syringae, Aeromonas hydrophila, Yersinia enterocolitica, Klebsiella pneumoniae Antibacterial Antimicrobial activity against B. cereus, S. aureus, E. coli, P. vulgaris, P. aeruginosa, Streptococcus, B. subtilis, A. hydrophila, L. monocytogenes [16]
Diethyl ether extract

Ethanol extract

Acetone extract		 Penicillum sp., Cladosporium sp., Fusarium oxysporum, F. culmorum, F. moniliforme, F. solani, Rhizopus sp, Aspergillus sp. Antifungal No antifungal activity detected [16]
Acetone extract TA98 and TA100 strains of S. typhimurium Antigenotoxicity ↑ Inhibition of frameshift mutations in TA98 than in TA100 [42]
Methanol extract Salmonella typhimurium TA1535 and TA1537

E. coli WP2uvrA

Human lymphocyte cells		 Antigenotoxicity Antimutagenic activity against Salmonella typhimurium

No activity against 		E. coli

↓ formation of SCE		 [43]
Methanol extract

Ethyl acetate extract		 Radical scavenging activity Antioxidant Methanol extract >>> ethyl acetate extract

Methanol extract: DPPH (IC		50 51.6 µg/mL); lipid peroxidation inhibition capacity (IC50 45.5 µg/mL); ferrous ion chelating capacity (IC50 50.4 µg/mL; hydroxyl radical scavenging activity (IC50 90.1 µg/mL) [22]
  Methanol extract Human lymphocytes cells Antioxidant ↑ SOD, GPX, MDA levels

↓ GSH		 [43]
  Acetone extract HeLa cells, A549 cells and 5RP7 cells Cytotoxic ↓ Cell viability [42]
  Methanol extract Salmonella typhimurium TA1535

E. coli WP2uvrA Genotoxicity No activity [43]
Cetraria islandica (L.) Ach Methanol extract

Acetone extract

Light petrolatum extract

Aqueous extract		 Helicobacter pylori Antibacterial Light petrolatum extract > Acetone extract [17]
Methanol extract Gram-positive: Staphylococcus aureus, Bacillus subtilis, Bacillus cereus

Gram negative: 		Escherichia coli, Proteus mirabilis Antibacterial Antimicrobial activity against all bacteria [18]
Methanol extract Aspergillus flavus, Candida albicans, Fusarium oxysporum, Penicillium purpurescen, Trichoderma harsianum Antifungal Antifungical activity against all fungi [18]
Aqueous extract Streptozotocin-induced Diabetes Mellitus type 1 Sprague-Dawley rats Antidiabetic Slight insulin increase

No inhibition of glucose levels

↓ infiltration of immune cells, vacuolization, and intensity of fibrosis in the kidney

↑ SOD and GSH, ↓ MDA		 [30]
Aqueous extract Streptozotocin-induced Diabetes Mellitus type 1 Sprague-Dawley rats Antidiabetic No body weight change

↓ glucose

↑ insulin levels

↑ SOD, CAT and GSH levels

↑ glycogen of hepatocytes

↓ intensity of fibrosis		 [31]
Aqueous Extract Streptozotocin-induced Diabetes Mellitus type 1 Sprague-Dawley rats Antidiabetic ↓ TOS

↑ TAC

↑ regeneration and erythropoiesis

↑ MCV, MCH, MCHC		 [29]
Cetraria islandica (L.) Ach Aqueous extract BSA-induced arthritis in rats Anti-inflammatory ↓ reduction in the diameter between the right and left knee [35]
Aqueous extract Streptozotocin-induced Diabetes Mellitus type 1 Sprague-Dawley rats Antioxidant ↑ SOD and CAT

↓ MDA level

Light prevention of pancreatic cells destruction		 [32]
Aqueous extract Streptozotocin-induced Diabetes Mellitus type 1 Sprague-Dawley rats Antioxidant ↑ SOD, GSH

↓ MDA levels

Prevention of renal cell destruction.		 [30]
Aqueous extract Human erythrocytes with type 1 diabetes mellitus Antioxidant ↑ SOD, CAT and GPx

↓ MDA levels		 [28]
Methanol extract Blood lymphocytes from human nonsmoking healthy volunteers Antioxidant ↑ SOD and GPx

↓ MDA		 [23]
Aqueous extract Radical scavenging activity Antioxidant 96–100% inhibition upon lipid peroxidation of linoleic acid system

↑ Superoxide radical scavenging activity		 [24]
Ethanol extract Radical scavenging activity Antioxidant DPPH, FRAP and ABTS [25]
Methanol extract Radical scavenging activity Antioxidant DPPH (IC50 678.3 μg/mL)

Superoxide anion scavenging activity (IC		50 792.4 μg/mL)

Reducing power range 0.0512 to 0.4562 μg/mL		 [18]
Melanin Radical scavenging activity Antioxidant DPPH (IC50 405 μg/mL) [27]
Protolichesterinic acid, Lichesterinic acid, Protocetraric acid, Fumarprotocetraric acid Trypanosoma brucei brucei Antitrypanosomal Protolichesterinic acid MIC value 12.5 µM

Lichesterinic acid MIC value 6.30 µM

Protocetraric acid and Fumarprotocetraric acid no antitrypanosomal activity detected		 [19]
β-1,3/1,4-Glucan lichenan Keratinocytes (NHEK) cells

HaCaT keratinocytes cells		 Cellular differentiation ↓ Proliferation

↑ CytoKeratin 10 (CK) in the cytoplasm

↑ Involucrin expression

Dose-dependent CK gene expression regulation

↑ Involucrin transcription levels

↑ Transglutaminase gene expression

Gene expression regulation of loricrin and filaggrin

↑ Gene group related to cellular differentiation		 [44]
Protolichesterinic acid A549 cells Cytotoxic No change in 5-lipoxygenase activity

↓ LRRC8A expression

↓ cell viability		 [39]
Protolichesterinic acid T-47D cells, K-562 cells and

ZR-75-1 cells		 Cytotoxic Morphological changes in T-47D and K-562

↓ Cell viability

↓ DNA synthesis

Inhibition of 5-lipoxygenase		 [38]
Ethanol extract MCF7 cells Cytotoxic ↓ Cell viability (IC50 9.2047 × 10−5 g/mL)

↓ PPAR-g levels

↑ AMPK-α1 and ERK1/2 levels

↑ Apoptotic cell percentage after 24 h

↓ P53, Caspase 3 and Bcl-2 dose dependent		 [37]
Methanol extract FemX and LS174 cells Cytotoxic FemX (IC50 22.6 μg/mL)

LS174 (IC		50 33.7 μg/mL) [18]
Cetraria islandica (L.) Ach Lichenan U937 cells Cytotoxic No active [41]
Methanol extract MCF-7 and HepG2 cells Cytotoxic MCF-7 (IC50 181.0 µg/mL)

HepG2 (IC		50 19.5 µg/mL) [33]
Fumarprotocetraric acid T-47D and Panc-1 Cytotoxic No antiproliferative effect [40]
Chloroform–methanol, extract Developing zebrafish embryos Depigmenting ↓ Pigmentation (IC50 44 µg/mL) [45]
Chloroform–methanol extract Radical scavenging activity

MeWo		 Depigmenting Tyrosinase inhibition (IC50 86 µg/mL)

Cell viability assay (IC		50 264 µg/mL)

↓ Melanin levels		 [45]
Aqueous extract Human erythrocytes with type 1 diabetes mellitus Genotoxicity ↑ Proliferation index

↓ DNA damage

↓ SCE		 [28]
Methanol extract Peripheral venous blood Genotoxicity ↑ Number of BN cells containing MNi and number of MNi in BN cells [18]
Aqueous extract

Fumarprotocetraric acid, Protolichesterinic acid, Lichenan and isolichenan		 Human monocytes differentiated into mature dendritic cells. Immunomodulating Aqueous extract and lichenan were active

↑ CD86 and ↓ CD209 and IL-12p40/IL-10		 [35]
(1 --> 3) -(1 --> 4)-α-D-Glucan polysaccharide Ci-3 Whole blood Immunomodulating ↑ Granulocytic phagocytosis

↓ Complementarily induced hemolysis		 [36]
Fumarprotocetraric acid Radical scavenging activity

SH-SY5Y and U373-MG cells		 Neuroprotective ORAC (5.07 μmol TE/mg), DPPH (IC50 1393.83 μg/mL)

↑ cell survival, GSH/GSSG

↓ lipid peroxidation, ROS caspase-3 activation

Avoid mitochondrial dysfunction and alterations in calcium homeostasis

↓ Pro-apoptotic signals

Nrf2 pathway		 [34]
Cetraria islandica (L.) Ach Methanol extract U373 MG cells Neuroprotective ORAC (3.06 µmol TE/mg), DPPH (IC50 1183.55 µg/mL)

↑ Cell viability and GSH/GSSG ratio

↓ ROS generation and lipid peroxidation		 [33]
Cetraria pinastri (Scop.) Gray. Methanol extract Gram-positive: Enterococcus fecalis, Staphylococcus aureus.

Gram-negative: 		Escherichia coli, Klebsiella pneumoniae Micrococcus lysodeikticus, Pseudomonas aeruginosa Antibacterial Antimicrobial activity against all bacterial strains [15]
Cetraria pinastri (Scop.) Gray. Methanol extract Alternaria alternate, Aspergillus flavus, A. niger, Candida albicans, Cladosporium cladosporioides, Paecilomyces variotii, Acremonium chrysogenum, Fusarium oxysporum, Penicillium verrucosum Trichoderma harsianum Antifungal Antifungal activity against all fungal species tested [15]
Cetraria pinastri (Scop.) Gray. Methanol extract Thiocyanate method Antioxidant 48.79% inhibition of the oxidation of linoleic acid [46]

References

  1. EMA/HMPC/36866/2014. Assessment Report on Cetraria islandica (L.) Acharius s.l., Thallus. 2014. Available online: https://www.ema.europa.eu/en/documents/herbal-report/draft-assessment-report-cetraria-islandica-l-acharius-sl-thallus-first-version_en.pdf (accessed on 25 March 2022).
  2. Ingólfsdóttir, K. Usnic acid. Phytochemistry 2002, 61, 729–736.
  3. Richardson, D.H.S. Medicinal and other economic aspects of lichens. In GALUN, M. CRC Handbook of Lichenology; CRC Press: Boca Raton, FL, USA, 1988; Volume III, pp. 93–108.
  4. Ahmadjian, V.; Nilsson, S. Swedish Lichens. In Yearbook 1963; Goddard, H., Ed.; American Swedish Historical Foundation: Philadelphia, PA, USA, 1963; pp. 39–47.
  5. Baytop, T. Therapy with Medicinal Plants in Turkey (Past and Present); Istanbul University: Istanbul, Turkey, 1999; pp. 1–233.
  6. Dülger, B.; Gulcin, F.; Aslan, A. Cetraria islandica (L) Ach. Likeninin Antimikrobiyal Aktivitesi. Turk. J. Biol. 1998, 22, 111–118.
  7. Agelet, A.; Vallès, J. Studies on pharmaceutical ethnobotany in the region of Pallars (Pyrenees, Catalonia, Iberian Peninsula). Part III. Medicinal uses of non-vascular plants. J. Ethnopharmacol. 2003, 84, 229–234.
  8. Gudjónsdóttir, G.A.; Ingólfsdóttir, K. Quantitative determination of protolichesterinic- and fumarprotocetraric acids in Cetraria islandica by high-performance liquid chromatography. J. Chromatogr. A 1997, 757, 303–306.
  9. Xu, M.; Heidmarsson, S.; Thorsteinsdottir, M.; Kreuzer, M.; Hawkins, J.; Omarsdottir, S.; Olafsdottir, E.S. Authentication of Iceland Moss (Cetraria islandica) by UPLC-QToF-MS chemical profiling and DNA barcoding. Food Chem. 2018, 245, 989–996.
  10. Airaksinen, M.M.; Peura, P.; Ala-Fossi-Salokangas, L.; Antere, S.; Lukkarinen, J.; Saikkonen, M.; Stenbäck, F. Toxicity of plant material used as emergency food during famines in Finland. J. Ethnopharmacol. 1986, 18, 273–296.
  11. Illana-Esteban, C. Edible Lichens. Boletín de la Sociedad Micológica de Madrid 2009, 33, 273–282.
  12. FDA. Food Additive Status List. 2021. Available online: https://www.fda.gov/food/food-additives-petitions/food-additive-status-list (accessed on 5 May 2022).
  13. Ivanova, D.; Ivanov, D. Ethnobotanical use of lichens: Lichens for food review. Scr. Sci. Med. 2009, 41, 11.
  14. Illana-Esteban, C. Líquenes usados en perfumería. Bol. Soc. Micol. Madr. 2016, 40, 217–223.
  15. Ranković, B.; Ranković, D.; Marić, D. Antioxidant and antimicrobial activity of some lichen species. Mikrobiologiia 2010, 79, 812–818.
  16. Türk, A.O.; Yilmaz, M.; Kivanç, M.; Türk, H. The antimicrobial activity of extracts of the lichen Cetraria aculeata and its protolichesterinic acid constituent. Z. Naturforsch. C J. Biosci. 2003, 58, 850–854.
  17. Ingolfsdottir, K.; Hjalmarsdottir, M.A.; Sigurdsson, A.; Gudjonsdottir, G.A.; Brynjolfsdottir, A.; Steingrimsson, O. In vitro susceptibility of Helicobacter pylori to protolichesterinic acid from the lichen Cetraria islandica. Antimicrob. Agents Chemother. 1997, 41, 215–217.
  18. Grujičić, D.; Stošić, I.; Kosanić, M.; Stanojković, T.; Ranković, B.; Milošević-Djordjević, O. Evaluation of in vitro antioxidant, antimicrobial, genotoxic and anticancer activities of lichen Cetraria islandica. Cytotechnology 2014, 66, 803–813.
  19. Igoli, J.O.; Gray, A.I.; Clements, C.J.; Kantheti, P.; Singla, R.K. Antitrypanosomal activity & docking studies of isolated constituents from the lichen Cetraria islandica: Possibly multifunctional scaffolds. Curr. Top. Med. Chem. 2014, 14, 1014–1021.
  20. Pisoschi, A.M.; Pop, A. The role of antioxidants in the chemistry of oxidative stress: A review. Eur. J. Med. Chem. 2015, 97, 55–74.
  21. Fernández-Moriano, C.; Gómez-Serranillos, M.P.; Crespo, A. Antioxidant potential of lichen species and their secondary metabolites. A systematic review. Pharm. Biol. 2016, 54, 1–17.
  22. Tomovic, J.; Rancic, A.; Vasiljević, P.; Maskovic, P.; Zivanovic, S.; Manojlovic, N.; Sovrlić, M. Antioxidant activity of lichen Cetraria aculeata. Prax. Med. 2015, 44, 107–113.
  23. Kotan, E.; Alpsoy, L.; Anar, M.; Aslan, A.; Agar, G. Protective role of methanol extract of Cetraria islandica (L.) against oxidative stress and genotoxic effects of AFB1 in human lymphocytes in vitro. Toxicol. Ind. Health 2011, 27, 599–605.
  24. Gülçin, I.; Oktay, M.; Küfrevioğlu, O.I.; Aslan, A. Determination of antioxidant activity of lichen Cetraria islandica (L) Ach. J. Ethnopharmacol. 2002, 79, 325–329.
  25. Stadnytska, N.; Fito, I.; Novikov, V.; Jasicka-Misiak, I.; Wieczorek, P. Effect of extraction solvent on total phenolic content, total flavonoid content and antioxidant activity of Cetraria islandica. Int. J. PharmTech Res. 2020, 13, 198–205.
  26. Kosanić, M.; Ranković, B. Antioxidant and Antimicrobial Properties of Some Lichens and Their Constituents. J. Med. Food 2011, 14, 1624–1630.
  27. Rassabina, A.E.; Gurjanov, O.P.; Beckett, R.P.; Minibayeva, F.V. Melanin from the Lichens Cetraria islandica and Pseudevernia furfuracea: Structural Features and Physicochemical Properties. Biochemistry 2020, 85, 623–628.
  28. Colak, S.; Geyikoglu, F.; Türkez, H.; Bakır, T.; Aslan, A. The ameliorative effect of Cetraria islandica against diabetes-induced genetic and oxidative damage in human blood. Pharm. Biol. 2013, 51, 1531–1537.
  29. Colak, S.; Geyikoğlu, F.; Aslan, A.; Deniz, G.Y. Effects of lichen extracts on haematological parameters of rats with experimental insulin-dependent diabetes mellitus. Toxicol. Ind. Health 2014, 30, 878–887.
  30. Bakır, T.; Geyikoglu, F.; Çolak, S.; Türkez, H.; Aslan, A.; Bakır, M. The effects of Cetraria islandica and Pseudevernia furfuracea extracts in normal and diabetic rats. Toxicol. Ind. Health 2015, 31, 1304–1317.
  31. Deniz, G.Y.; Geyikoğlu, F.; Türkez, H.; Bakır, T.; Çolak, S.; Aslan, A. The biochemical and histological effects of lichens in normal and diabetic rats. Toxicol. Ind. Health 2016, 32, 601–613.
  32. Çolak, S.; Geyikoğlu, F.; Bakır, T.; Türkez, H.; Aslan, A. Evaluating the toxic and beneficial effects of lichen extracts in normal and diabetic rats. Toxicol. Ind. Health 2016, 32, 1495–1504.
  33. Fernández-Moriano, C.; Divakar, P.K.; Crespo, A.; Gómez-Serranillos, M.P. Neuroprotective activity and cytotoxic potential of two Parmeliaceae lichens: Identification of active compounds. Phytomedicine 2015, 22, 847–855.
  34. Fernández-Moriano, C.; Divakar, P.K.; Crespo, A.; Gómez-Serranillos, M.P. Protective effects of lichen metabolites evernic and usnic acids against redox impairment-mediated cytotoxicity in central nervous system-like cells. Food. Chem. Toxicol. 2017, 105, 262–277.
  35. Freysdottir, J.; Omarsdottir, S.; Ingólfsdóttir, K.; Vikingsson, A.; Olafsdottir, E.S. In vitro and in vivo immunomodulating effects of traditionally prepared extract and purified compounds from Cetraria islandica. Int. Immunopharmacol. 2008, 8, 423–430.
  36. Olafsdottir, E.S.; Ingolfsdottir, K.; Barsett, H.; Paulsen, B.S.; Jurcic, K.; Wagner, H. Immunologically active (1→3)-(1→4)-α-D-Glucan from Cetraria islandica. Phytomedicine 1999, 6, 33–39.
  37. Güven, C.; Taskin, E.; Yumtutas, O.; Şener, L.; Ozay, Y.; Dal, F.; Ahbab, M.; Bozgeyik, I.; Albeniz, I.; Bagıs, H.; et al. The Anticancer Activity of Cetraria Islandica (L.) Ach in Breast Cancer Cells Through Crosstalk of Ampk-α1 and Erk1/2 Signalling. Turk. J. Agric.-Food Sci. Technol. 2018, 6, 783.
  38. Ogmundsdóttir, H.M.; Zoëga, G.M.; Gissurarson, S.R.; Ingólfsdóttir, K. Anti-proliferative effects of lichen-derived inhibitors of 5-lipoxygenase on malignant cell-lines and mitogen-stimulated lymphocytes. J. Pharm. Pharmacol. 1998, 50, 107–115.
  39. Thorsteinsdottir, U.A.; Thorsteinsdottir, M.; Lambert, I.H. Protolichesterinic Acid, Isolated from the Lichen Cetraria islandica, Reduces LRRC8A Expression and Volume-Sensitive Release of Organic Osmolytes in Human Lung Epithelial Cancer Cells. Phytother. Res. 2016, 30, 97–104.
  40. Kristmundsdóttir, T.; Jónsdóttir, E.; Ogmundsdóttir, H.M.; Ingólfsdóttir, K. Solubilization of poorly soluble lichen metabolites for biological testing on cell lines. Eur. J. Pharm. Sci. 2005, 24, 539–543.
  41. Pang, Z.; Otaka, K.; Maoka, T.; Hidaka, K.; Ishijima, S.; Oda, M.; Ohnishi, M. Structure of beta-glucan oligomer from laminarin and its effect on human monocytes to inhibit the proliferation of U937 cells. Biosci. Biotechnol. Biochem. 2005, 69, 553–558.
  42. Zeytinoglu, H.; Incesu, Z.; Tuylu, B.A.; Turk, A.O.; Barutca, B. Determination of genotoxic, antigenotoxic and cytotoxic potential of the extract from lichen Cetraria aculeata (Schreb.) Fr. in vitro. Phytother. Res. 2008, 22, 118–123.
  43. Ceker, S.; Orhan, F.; Sezen, S.; Gulluce, M.; Ozkan, H.; Aslan, A.; Agar, G. Anti-mutagenic and Anti-oxidant Potencies of Cetraria Aculeata (Schreb.) Fr., Cladonia Chlorophaea (Flörke ex Sommerf.) Spreng. and Cetrelia olivetorum (Nyl.) W.L. Culb. & C.F. Culb.). Iran. J. Pharm. Res. 2018, 17, 326–335.
  44. Zacharski, D.M.; Esch, S.; König, S.; Mormann, M.; Brandt, S.; Ulrich-Merzenich, G.; Hensel, A. β-1,3/1,4-Glucan Lichenan from Cetraria islandica (L.) ACH. induces cellular differentiation of human keratinocytes. Fitoterapia 2018, 129, 226–236.
  45. Malaspina, P.; Catellani, E.; Burlando, B.; Brignole, D.; Cornara, L.; Bazzicalupo, M.; Candiani, S.; Obino, V.; De Feo, V.; Caputo, L.; et al. Depigmenting potential of lichen extracts evaluated by in vitro and in vivo tests. PeerJ 2020, 8, e9150.
  46. Peterson, J.; Schmoldt, D.; Peterson, D. Guidelines for Evaluating Air Pollution Impacts on Class 1 Wilderness Areas in the Pacific Northwest; Gen. Tech. Rep. PNW-GTR-299; U.S. Department of Agriculture, Forest Service, Pacific Northwest Research Station: Portland, OR, USA, 1992; 83p.
More
© Text is available under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/)
ScholarVision Creations
Feedback